Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31150573

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Sep 19
First author
Zhang Y

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Sep;16(9):528. doi: 10.1038/s41571-019-0242-0.
    note
    Source null
    related pmid
    31197226
    relationship
    Comment in
  2. citation
    Lancet. 2024 Jun 22;403(10445):2667-2669. doi: 10.1016/S0140-6736(24)00810-9.
    note
    Source null
    related pmid
    38824939
    relationship
    Comment in

Authors and identifiers

  1. name
    Zhang Y
    type
    Author
  2. name
    Chen L
    type
    Author
  3. name
    Hu GQ
    type
    Author
  4. name
    Zhang N
    type
    Author
  5. name
    Zhu XD
    type
    Author
  6. name
    Yang KY
    type
    Author
  7. name
    Jin F
    type
    Author
  8. name
    Shi M
    type
    Author
  9. name
    Chen YP
    type
    Author
  10. name
    Hu WH
    type
    Author
  11. name
    Cheng ZB
    type
    Author
  12. name
    Wang SY
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Zhang Y
    type
    Author
  2. name
    Chen L
    type
    Author
  3. name
    Hu GQ
    type
    Author
  4. name
    Zhang N
    type
    Author
  5. name
    Zhu XD
    type
    Author
  6. name
    Yang KY
    type
    Author
  7. name
    Jin F
    type
    Author
  8. name
    Shi M
    type
    Author
  9. name
    Chen YP
    type
    Author
  10. name
    Hu WH
    type
    Author
  11. name
    Cheng ZB
    type
    Author
  12. name
    Wang SY
    type
    Author
bibliography ids
  1. nci-bib-c5f249fa5b4d6e52aba56adf
book metadata
content sha256
076e69aae1043285aca32e8ea1c52b5244459bc4235888661e08d609afd9121f
document type
citation
dois
  1. 10.1056/NEJMoa1905287
electronic publication date
display
2019 May 31
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31150573
immutable id
pubmed:31150573@076e69aae1043285aca32e8ea1c52b5244459bc4235888661e08d609afd9121f
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
12
name
The New England journal of medicine
nlm unique id
0255562
pages
1124-1135
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2019 Sep;16(9):528. doi: 10.1038/s41571-019-0242-0.
    note
    Source null
    related pmid
    31197226
    relationship
    Comment in
  2. citation
    Lancet. 2024 Jun 22;403(10445):2667-2669. doi: 10.1016/S0140-6736(24)00810-9.
    note
    Source null
    related pmid
    38824939
    relationship
    Comment in
outcomes validated
false
pmid
31150573
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
19a1989f319a9ba50c4e8c2de2011d616985755237d58122b368108c689a9c66
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Sep 19
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31150573/
title
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.

Preserved source evidence · Not medical advice